NICHOLAS BENITES: Open Payments
NPI 1174882807 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 35 payments from 8 companies in 2025. Trend: 2023 $608 · 2024 $731 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $427 |
| ABBVIE INC. | 11 | $146 |
| Janssen Biotech, Inc. | 2 | $39 |
| Incyte Corporation | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| LEO Pharma Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Bimzelx, SKYRIZI, TREMFYA, OPZELURA, COSENTYX, ANZUPGO, DUPIXENT, Sotyktu.
Industry payments across NV — which companies pay providers there.
